封面
市场调查报告书
商品编码
1634169

全球电外科设备市场 - 2025 - 2033

Global Electrosurgical Devices Market - 2025 - 2033

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年,全球电外科设备市场规模达62.7亿美元,预计2033年将达91亿美元,2025-2033年预测期间复合年增长率为3.7%。

电外科设备,也称为 Bovie,是一种用于切割、透过干燥破坏组织以及透过凝固血液控制出血的手术工具。它使用高功率发生器在探头和手术部位之间产生射频火花,造成局部加热和组织损伤。此发生器以两种模式运作:单极(主动电极将电流集中到该部位)和双极(两个电极都位于手术部位)。

市场动态:

驱动程式和限制

科技进步的崛起

技术进步极大地塑造了全球电外科设备市场,并提高了手术的精确度和安全性。这包括微创技术、机器人辅助系统和先进的基于能量的模式。这些进步可帮助医疗保健提供者实现更好的患者治疗效果,同时减少恢復时间和併发症。智慧型系统和资料分析的整合改进了设备功能。随着技术的发展,电外科设备在各个医学学科中被采用,促进了市场的成长。

例如,2024 年8 月,Olympus在其PowerSeal 密封机/分隔器产品组合中推出了两种新的钳口设计:PowerSeal 弯曲钳口,双动(SJDA) 和PowerSeal 弯曲钳口,单动(CJSA)。这些设备可支援手术期间的解剖、抓取和密封技术,提高手术效率和舒适度。奥林巴斯声称,与竞争对手的仪器相比,PowerSeal 设计需要更少的挤压力来闭合钳口,而不会影响钳口力道或密封能力。这些一次性设备可用于腹腔镜和开放性手术。

设备成本高

由于先进技术的成本高昂,全球电外科设备市场面临挑战,这对中低收入地区的医疗机构来说是一个重大障碍。这些成本,加上对专门培训和技术专长的需求,可能会限制获得最先进设备的机会。儘管有改善手术效果和效率的潜力,但这些设备的高成本可能会阻碍其广泛采用。

例如,电外科设备的价格从 5000 美元到 15,000 美元不等,美国的知名品牌有 Covidien、Ellman 和 Erbe 等。美国以外最畅销的品牌包括 Conmed 和 Sometech。新机和演示机比翻新机或二手机贵。新机器有製造商保固并且从未使用过,而演示机器是展览模型。翻新机器经过改进,可以在製造商的工厂或私人维修店进行

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 科技进步的崛起
    • 限制
      • 设备成本高
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章:依产品类型

  • 电外科器械
    • 双极性
    • 单极
  • 电外科配件
  • 电外科发生器
  • 电灼装置
  • 氩气和烟雾管理系统

第 7 章:按申请

  • 一般外科
  • 妇科手术
  • 泌尿科
  • 骨科手术
  • 心血管外科
  • 整容手术
  • 神经外科
  • 其他的

第 8 章:最终用户

  • 医院
  • 专科诊所
  • 其他的

第 9 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Stryker Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Boston Scientific Corporation
  • Symmetry Surgical Inc
  • CONMED Corporation
  • Medtronic Plc
  • Ethicon (Johnson and Johnson)
  • B. Braun SE
  • Smith+Nephew
  • Olympus Corporation
  • Abbott Laboratories

第 12 章:附录

简介目录
Product Code: MD1358

The global electrosurgical devices market reached US$ 6.27 billion in 2023 and is expected to reach US$ 9.10 billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.

The electrosurgical unit, also known as the Bovie, is a surgical tool used to incise, destroy tissue through desiccation, and control bleeding by coagulating blood. It uses a high-powered generator to produce a radiofrequency spark between a probe and the surgical site, causing localized heating and tissue damage. The generator operates in two modes: monopolar, where an active electrode concentrates current to the site, and bipolar, where both electrodes are located at the surgical site.

Market Dynamics: Drivers & Restraints

Rise in Technological Advancements

Technological advancements have significantly shaped the global electrosurgical devices market, enhancing precision and safety in procedures. This includes minimally invasive techniques, robotic-assisted systems, and advanced energy-based modalities. These advancements help healthcare providers achieve better patient outcomes with reduced recovery times and complications. The integration of intelligent systems and data analytics has improved device functionality. As technology evolves, electrosurgical devices are adopted across various medical disciplines, contributing to the market's growth.

For instance, in August 2024, Olympus has introduced two new jaw designs in its PowerSeal sealer/divider portfolio: the PowerSeal Curved Jaw, double-action (SJDA) and PowerSeal Curved Jaw, single-action (CJSA). These devices support dissection, grasping, and sealing techniques during surgery, promoting procedural efficiency and comfort. Olympus claims that the PowerSeal design requires less squeeze force than competitor instruments to close the jaws, without compromising jaw force or sealing capability. These single-use devices can be used in laparoscopic and open surgery.

High Cost of the Devices

The global electrosurgical devices market faces challenges due to the high cost of advanced technologies, a significant barrier for healthcare facilities in low- and middle-income regions. These costs, coupled with the need for specialized training and technical expertise, can limit access to state-of-the-art equipment. Despite the potential to improve surgical outcomes and efficiency, the high cost of these devices may hinder their widespread adoption.

For instance, Electrosurgical devices can range from $5000 to $15,000 USD, with well-known brands like Covidien, Ellman, and Erbe in the US. Top-selling brands outside the US include Conmed and Sometech. New and demo machines are more expensive than refurbished or used ones. New machines have a manufacturer's warranty and are never used, while demo machines are exhibition models. Refurbished machines have undergone improvements and can be done at the manufacturer's facilities or private repair shops

Segment Analysis

The global electrosurgical devices market is segmented based on product type, application, end user and region.

Product Type:

Electrosurgical Instruments segment is expected to dominate the Electrosurgical Devices market share

The electrosurgical instruments segment holds a major portion of the electrosurgical devices market share and is expected to continue to hold a significant portion of the electrosurgical devices market share during the forecast period.

Electrosurgical instruments, including electrodes, forceps, scissors, and probes, are crucial for precision and minimal tissue damage in various surgical procedures. They are versatile and used in general surgery, gynecology, urology, and orthopedics. Innovations in design, like non-stick coatings and ergonomics, enhance their effectiveness and safety. As demand for minimally invasive procedures increases, the adoption of advanced electrosurgical instruments is expected to drive market expansion, meeting healthcare providers' needs for reliable and efficient surgical tools.

For instance, in January 2023, Cook Medical has introduced a new, streamlined portfolio of urological bipolar electrodes in the U.S., focusing on the most frequently used products for bladder and prostate procedures. The portfolio includes seven products, six of which are specifically designed for transurethral resection, ablation, and soft tissue removal of the prostate and bladder, and where hemostasis is required. The streamlined portfolio is designed to meet the needs of urologists in the field.

Application:

General Surgery segment is the fastest-growing segment in Electrosurgical Devices market share

The general surgery segment is the fastest-growing segment in the electrosurgical devices market share and is expected to hold the market share over the forecast period.

The global electrosurgical devices market is primarily driven by general surgery, which uses these tools for cutting, coagulating, and tissue ablation. These devices offer precision and efficiency, reducing recovery time, blood loss, and complications. As conditions like hernias, appendicitis, and gastrointestinal disorders increase, the demand for electrosurgical devices in general surgery is expected to grow. Advancements in electrosurgical technologies further enhance their application in general surgery, solidifying their critical role in this market segment.

For instance, in 2023, as per NCBI study in the US found that 1 in 9 US households had undergone at least one surgical procedure in the past year, with the highest prevalence among those 65 and older and Medicare beneficiaries, with approximately 1 in 5 reporting such procedures.

Geographical Analysis

North America holds a substantial position in the electrosurgical devices market and is expected to hold most of the market share due to significant investments in medical technologies, and high prevalence of chronic diseases. The region's strong base of leading medical device manufacturers and research institutions drives innovation in electrosurgical technologies. Government initiatives like favorable reimbursement policies and funding for medical advancements contribute to market growth. The widespread adoption of minimally invasive surgical procedures and skilled healthcare professionals further enhance the use of electrosurgical devices.

For instance, in June 2023, Olympus Corporation has announced the availability of its latest electrosurgical generator, the ESG-410, for treating bladder cancer and enlarged prostate. This next-generation generator offers efficiencies in treating NMIBC (non-muscle-invasive bladder cancer) and BPH (enlarged prostate), using various resection loops, band electrodes, and vaporization buttons and needles. The generator supports options and efficiencies in the treatment of these conditions.

Europe is growing at the fastest pace in the Electrosurgical Devices market

Europe holds the fastest pace in the electrosurgical devices market and is expected to hold most of the market share due to established healthcare system and robust regulatory frameworks. The region's focus on improving surgical outcomes and patient safety has led to widespread adoption of advanced electrosurgical technologies. The growing aging population and increasing incidence of chronic diseases like diabetes, cancer, and cardiovascular conditions increase the demand for surgical procedures. Europe's leading medical device manufacturers and research organizations contribute to technological advancements and product development. Government initiatives, reimbursement policies, training programs, and collaborations between healthcare providers and manufacturers further drive market growth.

For instance, in November 2024, Halma PLC has acquired Lamidey Noury Medical for EUR50 Billion, aiming to expand its Healthcare sector. The Paris-based electrosurgical device firm, which is used in urology, gynaecology, and general surgery, is a minimally invasive option used in over 60 countries. The acquisition is funded by existing lending facilities. LNM generated EUR13.6 billion in revenue from the 12 months to October, meeting Halma's target range of 19% to 23%.

Competitive Landscape

The major global players in the electrosurgical devices market include Stryker Corporation, Boston Scientific Corporation, Symmetry Surgical Inc, CONMED Corporation, Medtronic Plc, Ethicon (Johnson and Johnson), B. Braun SE, Smith+Nephew, Olympus Corporation, Abbott Laboratories, OTTek, Dalent Medical, MMI, EGDe Surgical and among others.

Key Developments

  • In September 2024, Mindray, a leading global medical equipment manufacturer, showcased its UP700 Electrosurgical Unit at the 27th International Federation for the Surgery of Obesity and Metabolic Disorders World Congress in Melbourne, Australia. The UP700 Electrosurgical Unit was the highlight of the cutting-edge innovations in bariatric and metabolic surgery.
  • In April 2023, Innoblative Designs, Inc., a private medical device company, has received Breakthrough Device Designation from the FDA for its SIRA RFA Electrosurgical Device, designed for use in breast cancer patients undergoing lumpectomy.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global electrosurgical devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of the Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Electrosurgical Instruments*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Bipolar
    • 6.2.4. Monopolar
  • 6.3. Electro surgery Accessories
  • 6.4. Electrosurgical Generators
  • 6.5. Electrocautery Devices
  • 6.6. Argon and Smoke Management Systems

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. General Surgery *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gynecology Surgery
  • 7.4. Urologic Surgery
  • 7.5. Orthopedic Surgery
  • 7.6. Cardiovascular Surgery
  • 7.7. Cosmetic Surgery
  • 7.8. Neurosurgery
  • 7.9. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialized Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Stryker Corporation *
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Boston Scientific Corporation
  • 11.3. Symmetry Surgical Inc
  • 11.4. CONMED Corporation
  • 11.5. Medtronic Plc
  • 11.6. Ethicon (Johnson and Johnson)
  • 11.7. B. Braun SE
  • 11.8. Smith+Nephew
  • 11.9. Olympus Corporation
  • 11.10. Abbott Laboratories

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us